返回
H
Han Sun
Dalian Maritime University
22H指数
260论文数
1.7K被引数
收录论文 51
发表时间
Asia subgroup overall survival and long-term follow-up results of the phase IIb HERIZON-BTC-01 study: Zanidatamab in previously treated human epidermal growth factor receptor 2 (HER2)-amplified biliary tract cancer (BTC)亚洲亚组总生存期和长期随访结果:IIb期HERIZON-BTC-01研究——Zanidatamab用于既往接受过治疗的表皮生长因子受体2(HER2)扩增的胆道癌(BTC)
ANNALS OF ONCOLOGY
IF65.4

